ecent histological studies have shown that acute coronary events are caused by ruptured, eroded or spot-calcified plaque. 1 According to retrospective studies, the most common cause of acute coronary syndrome (ACS) appears to be plaque rupture. [2] [3] [4] Plaque that is vulnerable to rupture has a large lipid-rich core and thin fibrous cap with macrophage and lymphocyte infiltration, and a decreased smooth muscle cell component. Recent observations by intravascular ultrasound (IVUS) have consistently suggested that the majority of patients with ACS have previously ruptured coronary artery plaque in the nonculprit coronary arteries in addition to the infarct-related culprit arteries. [5] [6] [7] Furthermore, a study by coronary angioscopy 8 has shown that the majority of patients (91%) with evolving ACS have yellow plaque, the marker of plaque vulnerability, 9 in the non-culprit coronary arteries. Taken together, these studies indicate that ACS occurs as a consequence of the simultaneous development of vulnerable plaque in the whole coronary artery system. The diagnostic modalities, however, are limited in their application by their invasive nature, and they are not appropriate for routine clinical assessment of plaque in sites remote from the culprit coronary arteries.
Multislice computed tomography (MSCT) enables detection of coronary artery stenoses and occlusions, 10, 11 and also an evaluation of vulnerable plaque characterized by low computed tomography (CT) density. [12] [13] [14] [15] Therefore, MSCT has the potential to become a minimally invasive method of evaluating the plaque texture in the non-culprit coronary artery lesions.
In the present study, we hypothesized that MSCT coronary angiography would detect vulnerable plaques more frequently in non-culprit coronary arteries in patients with ACS than in those with non-ACS.
Methods

Patients
Seventy-four patients with angiographically documented coronary artery disease underwent MSCT coronary angiography. Patients were divided into the following 2 groups: ACS group and non-ACS group. The ACS group comprised 21 patients (15 patients with acute myocardial infarction and 6 patients with unstable angina), and the non-ACS group had 53 patients (45 patients with stable angina, 4 patients with silent myocardial ischemia and 4 patients with old myocardial infarction occurring at least 1 year previously). Acute myocardial infarction was defined as the occurrence of typical symptoms, electrocardiographic (ECG) evidence of acute myocardial infarction (ST elevation of at least 0.1 mV in 2 or more leads), coronary angiographic findings of acute myocardial infarction (occlusion of a main coronary artery branch with Thrombolysis in Myocardial Infarction grade 0, 1, or 2 flow), and a serum creatine kinase (CK) activity twice the upper limit of normal. 16 angiographic evidence of a stenosis >50% in 1 or more principal coronary arteries, and no increase in the serum CK activity. Stable angina was defined by symptoms of typical precordial chest pain and coronary angiographic findings of a stenosis >50% in 1 or more principal coronary arteries. Nineteen patients had undergone percutaneous coronary intervention of the culprit lesion (stent implantation in 16, directional atherectomy in 2 and percutaneous balloon angioplasty in 1). The location of the culprit lesion was the left anterior descending artery in 11, the left circumflex artery in 1, and the right coronary artery in 7 patients. Exclusion criteria included (1) chronic atrial fibrillation, (2) deteriorating renal function, (3) pregnancy, hyperthyroidism, or a known allergic reaction to contrast media, (4) severe left ventricular dysfunction (left ventricular ejection fraction <30%), or (5) known history of bronchial asthma with a contraindication to -blocker use. The study was approved by the hospital's ethics committee and informed consent was obtained from all patients.
MSCT MSCT (Aquillion 16, Toshiba Medical, Tokyo, Japan) was performed within 4 weeks from the onset of chest pain in the ACS group and within 24.7±22.6 days (range 1-91 days) prior to and 29.9±17.6 days (range 12-63 days) after angiographic studies in the non-ACS group. Patients received metoprolol (20-60 mg) 1 h before the MSCT scan if the heart rate was >68 beats/min in order to perform the half reconstruction algorithm. Sublingual nitroglycerin (0.3 mg, Myocol Spray, Toa Eiyo, Tokyo, Japan) also was administered 5 min prior to the scan. Image acquisition was performed during an inspiratory breath hold preceded by inhalation of oxygen (4.0 L/min). A bolus of 80 ml contrast agent (Optiray 320, Tyco Healthcare, Tokyo, Japan) was injected intravenously at a rate of 3.0 ml/s. As soon as the signal density level in the ascending aorta reached a predefined threshold of 100 Hounsfield units (HU), acquisition of the CT data and the ECG trace were started. The volume data set for coronary artery imaging was acquired in spiral mode, with a collimation of 16×0.5 mm, a gantry rotation of 400 ms, helical pitch of 3.2, tube energy of 120 kV, and an effective tube current of 400 mA. The patient's ECG was digitized and monitored continuously during image acquisition.
MSCT Image Reconstruction and Plaque Evaluation
The raw data from the scans were reconstructed using a half-scan algorithm in all patients. The end of the reconstruction period was set at the peak of the P wave on the monitoring ECG. 11, 17 The reconstructed image data from the MSCT angiography were transferred to a computer workstation (M900 quadra, AMIN, Tokyo, Japan) for post processing.
Following visual inspection of the volume-rendered images, which depicted the gross configuration of the coronary artery lumen, the coronary artery plaques were inspected carefully on both the axial and curved multiplanar reconstruction images. Coronary artery lesions in the nonculprit, remote coronary arteries were evaluated on the axial and cross-sectional multiplanar reconstruction images. Coronary artery lesions were identified as non-calcified plaque when they occupied more than 25% of the coronary lumen and were low density. Four randomly selected regions of interest (≥1.0 mm 2 ) were positioned within each plaque, and the lowest CT density was defined as the minimum. The analysis of the plaques was performed for all major coronary arteries with a diameter ≥2.0 mm. When there were multiple non-calcified plaques in the non-culprit coronary artery, the plaque with the lowest CT density was analyzed. Plaques with the lowest CT density (<68 HU) were considered as CT-low-density plaques, based on IVUS observations described later.
We evaluated the images with a window level of 83 HU and a width of 230 HU for non-calcified plaques, and those with 400 HU and 900 HU, respectively, for the identification of calcified plaques. Severely calcified plaques accompanying appreciable artifact were not analyzed.
Definition of CT-Low-Density Plaque by IVUS
IVUS of the culprit arteries was performed in another series of 38 lesions (28 patients: 19 with ACS and 9 with non-ACS). All IVUS studies were of the de novo lesions in the culprit arteries as described previously. 18 The CT density of soft plaques on IVUS was determined. Soft plaque was defined as plaque tissue with an echogenicity lower than the adventitia. Hypoechoic plaque was defined as plaque tissue with an echogenicity lower than the adventitia. 12, 14, 15, 19 The lesions visualized by MSCT were identified on IVUS using landmarks such as bifurcations, the distance from the coronary artery ostia and branches. CT-low-density plaque on MSCT was defined as plaque with a density less than the mean density + 2 standard deviations (SD).
Statistics
Statistical analyses were performed using SPSS software (version 11.0) (SPSS Inc, Chicago, ILL, USA). Continuous variables were described by their means and standard deviations. Analysis of variance followed by Bonferroni/Dunn was used to compare the mean of plaque density, age and high-sensitivity C-reactive protein (hsCRP) between the ACS and non-ACS groups. The percentage of those having coronary risk factors and CT-low-density plaques were compared between the 2 groups by chi-square analysis. Linear regression analysis was performed to determine interobserver variability in plaque CT density measurements. For the evaluation of image quality, 2 observers judged each coronary artery as assessable or non-assessable for plaque density measurements. Cohen's kappa was calculated for the interobserver variability. The interobserver variability for the measurement of CT densities within the plaque was evaluated by Pearson's correlation.
Results
The patient characteristics are summarized in Table 1 . ACS patients were younger than non-ACS patients, but there were no statistical differences between the 2 groups in the incidence of diabetes mellitus (patients receiving longterm insulin, oral hypoglycemic therapy, or with fasting blood glucose >126 mg/dl), hypertension (patients receiving long-term antihypertensive medication), hypercholesterolemia (patients being treated with a cholesterol-lowering diet or medication, or having a total serum cholesterol level >220 mg/dl) and statin use. The hsCRP value was comparable between groups and there was no statistical difference.
MSCT scans of sufficient quality for plaque evaluation were obtained without complications in all 74 patients (the kappa value was 1.0). The scan was generally completed within 10 min and post-processing and data evaluation required 20-30 min depending on the complexity of the coronary artery. The mean heart rate at the beginning of imaging was 56±7.4 beats/min and increased to 65±7.5 beats/min at the end of the scan.
Plaque Texture
Pearson's analysis revealed that there was an excellent correlation in the evaluation of plaque CT density between the 2 observers (observer A: range 6-137 HU, mean 65.8± 34.1 HU, median 59.5 HU; observer B: range 7-143 HU, mean 67.3±35.3 HU, median 59.5 HU, R 2 =0.85, p<0.0001, Fig 1A) . Twenty two of 38 plaques were identified as soft plaques on IVUS. The mean plaque CT density of IVUSdefined soft plaques was 33.7±16.9 HU (range 4-65 HU, Fig 1B) . The upper limit of the CT density was 67.5 (mean + 2 SD) and plaques were defined as CT-low-density when they had a density <68 HU on MSCT. Non-calcified plaques were detected in 16 of 21 (76%) patients with ACS and in 30 of 53 (57%) patients with non-ACS, although the difference did not reach statistical significance (p=0.18, Fig 2A) . Non-calcified plaques of non-culprit coronary arteries were defined as CT-low-density plaques in 13 of 16 (81%) patients with ACS and in 13 of 30 (43%) patients with non-ACS and the incidence of CT-low-density plaques among non-calcified lesions was significantly higher in patients with ACS than in those with non-ACS (p=0.03, Fig 2B) . The number and locations of both the non-calcified and CT-low-density plaques in non-culprit coronary arteries is shown in Table 2 . In addition, the lowest CT density in the non-culprit lesions was significantly lower in the ACS group than in the non-ACS group (44.1±22.9 and 77.3± 33.7 HU, respectively, p=0.001, Fig 3) . Representative MSCT images in a patient with ACS and one with non-ACS are shown in Figs 4 and 5, respectively.
Discussion
Our study showed that patients with ACS more frequently had CT-low-density plaques in their non-culprit coronary arteries than patients with non-ACS. We also showed that the minimum CT density within the plaque was significantly lower in ACS patients than in those with non-ACS. These findings are consistent with previous studies using IVUS, which showed that the majority of patients with ACS had multiple plaque ruptures in the non-culprit coronary artery. [5] [6] [7] The presence of rupture-prone, vulnerable plaques in non-culprit coronary arteries has also been observed by coronary angioscopy. 8 Taken together, these findings, including those from the present study, suggest that ACS is a consequence of simultaneous development of vulnerable plaques in the whole coronary artery system. Recent observations have suggested that ACS is frequently associated with inflammation, as documented by the increase in hsCRP levels 20 and circulating cytokines and with the increased fibrinolysis status. 21 In fact, Hong et al 6 and Tanaka et al 7 found an association between elevated hsCRP levels and the presence of plaque rupture in their IVUS studies, although our study did not show statistical difference in hsCRP levels between patients with and without ACS.
Study Implications
Although a culprit lesion is clinically important in the early phase of ACS and is usually treated by catheter intervention, a certain number of patients develop plaque ruptures in sites remote from the culprit coronary artery. Thus, detection of rupture-prone, vulnerable coronary artery plaques in the whole coronary artery system is essential for therapeutic decision making. For example, aggressive lipidlowering therapy by statins should be considered if there are not only culprit lesions but also additional atherosclerotic lesions in remote sites. Although IVUS is the gold-standard for detecting and characterizing plaques, it is limited by its invasive nature and cannot be performed for nonculprit coronary arteries in the routine clinical setting. Our study suggests that coronary MSCT angiography is an appropriate substitute of IVUS for such purposes.
Study Limitations
First, the spatial resolution (0.5 mm) of our MSCT equipment limited the fine morphological assessment of plaque texture, such as thickness of the fibrous caps and the volume of the lipid core. Thus, accurate assessment of vulnerable plaque is not possible with this technique. Second, the frequent observation of thrombus associated with ruptured plaques in non-culprit arteries in patients with ACS might have resulted in erroneous CT measurements. At present, there are no data concerning the ability of MSCT to distinguish thrombi from non-calcified plaques. We excluded heavily calcified plaques from the analysis because the partial volume effect from calcification might have led to erroneous CT density measurements. However, a recent observation suggests that rupture occurs frequently in patients with acute myocardial infarction and plaques with spotty calcification. 22 Exclusion of calcified plaques might have resulted in underestimation of the total plaque burden in ACS patients. Third, our definition of CT-lowdensity plaques (<68 HU) was based on a small number of lesions (n=22) detected on IVUS. However, no direct comparison has been made between the plaque CT density obtained by 16-detector-row CT, which provides slice thickness of 0.5 mm, and plaque morphology on IVUS. CT density may vary depending on the slice thickness and density of the contrast-enhanced arterial lumen, and on the complexity of plaque composition. More detailed observations are definitely needed to define the morphological features of MSCT-detected plaque in comparison with other imaging modalities used to assess plaque vulnerability, such as coronary angioscopy and optical coherent tomography.
These limitations aside, our study demonstrated the feasibility of using MSCT to evaluate plaque texture. Because ACS appears to be a consequence of plaque development within the total coronary system, a long-term, prospective study is definitely needed to assess the incidence of future coronary events in ACS patients who have CT-low-density plaques in the non-culprit coronary arteries.
